Tevogen Inc. SEC filings TVGNW
Tevogen Inc. has 309 filings in SEC EDGAR's recent list, going back to Jun 10, 2021. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Nov 4, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Officer or director change
|
Nov 3, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Other events
|
Sep 30, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 16, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Other events
|
Sep 10, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Aug 26, 2026 | Aug 24, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 30, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Listing notice
|
Apr 22, 2026 | Apr 16, 2026 |
| 8-K |
Current report
Other events
|
Mar 25, 2026 | Mar 20, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 4, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Feb 25, 2026 | Feb 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 30, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 26, 2025 | Sep 23, 2025 |
| 8-K |
Current report
Other events
|
Jul 10, 2025 | Jul 10, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 3, 2025 | Jul 3, 2025 |
| 8-K |
Current report
Other events
|
Jun 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2025 | Jun 23, 2025 |
| 8-K |
Current report
Material agreement
|
Jun 3, 2025 | May 30, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 25, 2025 | Apr 21, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 17, 2025 | Apr 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 28, 2025 | Jan 28, 2025 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale
|
Aug 26, 2024 | Aug 20, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change
|
Aug 23, 2024 | Aug 20, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended, Listing notice
|
Jun 21, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 11, 2024 | Jun 6, 2024 |
| 8-K/A | Amended current report | May 30, 2024 | Feb 14, 2024 |
| 8-K |
Current report
Material agreement
|
May 16, 2024 | May 10, 2024 |
| 8-K |
Current report
Auditor change
|
May 2, 2024 | Apr 29, 2024 |
| 8-K/A | Amended current report | Apr 29, 2024 | Feb 14, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 26, 2024 | Apr 26, 2024 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
|
Apr 10, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change
|
Apr 2, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 21, 2024 | Mar 15, 2024 |
| 8-K | Current report | Feb 21, 2024 | Feb 14, 2024 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale, Other events
|
Feb 20, 2024 | Feb 14, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change
|
Feb 14, 2024 | Feb 14, 2024 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Feb 1, 2024 | Jan 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 24, 2024 | Jan 24, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2024 | Jan 4, 2024 |
| 8-K/A |
Amended current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Dec 19, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Dec 18, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 17, 2023 | Nov 17, 2023 |
| 8-K |
Current report
Other events
|
Sep 29, 2023 | Sep 28, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 14, 2023 | Sep 14, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 29, 2023 | Jun 28, 2023 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Jun 7, 2023 | Jun 7, 2023 |
| 8-K |
Current report
Material agreement, Listing notice
|
May 9, 2023 | May 4, 2023 |
| 8-K |
Current report
Listing notice
|
Apr 7, 2023 | Apr 4, 2023 |
| 8-K |
Current report
Listing notice
|
Mar 29, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Feb 9, 2023 | Feb 3, 2023 |
| 8-K |
Current report
Other events
|
Jan 31, 2023 | Jan 30, 2023 |
| 8-K |
Current report
Other events
|
Jan 26, 2023 | Jan 26, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2022 | Apr 13, 2022 |
| 8-K |
Current report
Other events
|
Dec 30, 2021 | Dec 30, 2021 |
| 8-K |
Current report
Other events
|
Nov 15, 2021 | Nov 8, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Other events
|
Nov 8, 2021 | Nov 3, 2021 |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- TVGN (Nasdaq), TVGNW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Warren, NJ
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1860871
- Former names
- Tevogen Bio Holdings Inc. (until Jul 30, 2026); Semper Paratus Acquisition Corp (until Feb 15, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.